Patrick J Gonyo

1 publication 2012 – 2012
Cell DifferentiationGraft vs Host DiseaseForkhead Transcription FactorsBone Marrow TransplantationCD8 Antigens

What does Patrick J Gonyo research?

Dr. Gonyo studies graft-versus-host disease, a condition where transplanted immune cells attack the recipient's healthy tissues after stem cell transplants. He investigates how the body generates a unique type of immune cell, known as CD8+ Foxp3+ regulatory T cells, in response to this condition. These cells help control the immune system and calm down the harmful attacks that occur during GVHD. By understanding this process, Dr. Gonyo aims to find new ways to improve treatments for patients who undergo stem cell transplants, ultimately reducing complications and improving outcomes.

Key findings

  • The induction of CD8+ Foxp3+ regulatory T cells during graft-versus-host disease helps reduce its severity.
  • These new immune cells act independently to suppress harmful immune responses, even in the absence of traditional regulatory T cells.
  • This discovery highlights a potential backup mechanism the body uses, which could be targeted for new therapies to prevent transplant complications.

Frequently asked questions

Does Dr. Gonyo study graft-versus-host disease?
Yes, Dr. Gonyo's research specifically focuses on understanding graft-versus-host disease and how the body responds to it.
What treatments has Dr. Gonyo researched?
He is exploring new treatments that could leverage the body's natural immune responses to reduce complications from stem cell transplants.
Is Dr. Gonyo's work relevant to stem cell transplant patients?
Absolutely, his findings are directly related to improving the health outcomes of patients undergoing stem cell transplants.

Publications in plain English

CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity.

2012

Journal of immunology (Baltimore, Md. : 1950)

Beres AJ, Haribhai D, Chadwick AC, Gonyo PJ, Williams CB +1 more

Plain English
Researchers discovered a new type of immune cell (CD8+ Foxp3+ cells) that the body creates when transplant patients develop graft-versus-host disease, a serious condition where transplanted immune cells attack the patient's own tissues. These newly discovered cells act as peacekeepers—they suppress the harmful immune response and reduce disease severity, and they can even do this job alone if the body can't make the traditional peacekeeping cells that scientists previously knew about. This matters because it reveals a backup mechanism the body uses to protect itself after stem cell transplants, which could lead to new treatments to prevent or reduce transplant complications.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.